The potential of the CMB305 vaccine regimen to target NY-ESO-1 and improve outcomes for synovial sarcoma and myxoid/round cell liposarcoma patients

by Seth M. Pollack
Published 2018-02-01

Targeting cancer testis antigens in synovial sarcoma

by Geoffrey Mitchell, Seth M Pollack, Michael J Wagner
Published 2021-06-01

Trabectedin in Soft Tissue Sarcomas

by Bradley J. Petek, Elizabeth T. Loggers, Seth M. Pollack, Robin L. Jones
Published 2015-02-01

Immune-Based Therapies for Sarcoma

by Seth M. Pollack, Elizabeth T. Loggers, Eve T. Rodler, Cassian Yee, Robin L. Jones
Published 2011-01-01

Systemic therapy in primary angiosarcoma of the spleen

by Robin L. Jones, Seth M. Pollack, Bruna Pellini Ferreira, Eve T. Rodler, Elizabeth T. Loggers
Published 2012-10-01

Response to PD1 inhibition in conventional chondrosarcoma

by Michael J. Wagner, Robert W. Ricciotti, Jose Mantilla, Elizabeth T. Loggers, Seth M. Pollack, Lee D. Cranmer
Published 2018-09-01

The imaging and pathological features of metastatic leiomyosarcoma in the gallbladder

by Yi Guo, Eleanor Chen, Darin J. Davidson, Venu G. Pillarisetty, Robin L. Jones, Seth M. Pollack
Published 2016-12-01

Multiple liver abscess formation and primary gastrointestinal stromal tumor

by Amy E. Chang, Gary N. Mann, Benjamin Hoch, Elizabeth T. Loggers, Seth M. Pollack, Orpheus Kolokythas, Robin L. Jones
Published 2013-09-01

Durable tumor regression in highly refractory metastatic KIT/PDGFRA wild-type GIST following treatment with nivolumab

by Brett A. Schroeder, Karan Kohli, Ryan B. O’Malley, Theresa S. Kim, Robin L. Jones, Robert H. Pierce, Seth M. Pollack
Published 2020-01-01

Socio-economic factors do not affect overall survival in soft tissue sarcoma when patients treated at a single high-volume center

by Boryana M. Eastman, Daniel S. Hippe, Landon S. Wootton, Matthew J. Nyflot, Matthew J. Thompson, Seth M. Pollack, Edward Kim, Matthew B. Spraker
Published 2021-05-01

Systemic Anti-Cancer Therapy in Synovial Sarcoma: A Systematic Review

by Richard F. Riedel, Robin L. Jones, Antoine Italiano, Chet Bohac, Juliette C. Thompson, Kerstin Mueller, Zaeem Khan, Seth M. Pollack, Brian A. Van Tine
Published 2018-11-01

A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin

by Jiyong Liang, Dexing Fang, Joy Gumin, Hinda Najem, Moloud Sooreshjani, Renduo Song, Aria Sabbagh, Ling-Yuan Kong, Joseph Duffy, Irina V. Balyasnikova, Seth M. Pollack, Vinay K. Puduvalli, Amy B. Heimberger
Published 2023-02-01

NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine.

by Seth M Pollack, Yonqing Li, Megan J Blaisdell, Erik A Farrar, Jeffrey Chou, Benjamin L Hoch, Elizabeth T Loggers, Eve Rodler, Janet F Eary, Ernest U Conrad, Robin L Jones, Cassian Yee
Published 2012-01-01

Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatment.

by Kendall C Shibuya, Vikas K Goel, Wei Xiong, Jonathan G Sham, Seth M Pollack, Allison M Leahy, Samuel H Whiting, Matthew M Yeh, Cassian Yee, Stanley R Riddell, Venu G Pillarisetty
Published 2014-01-01

Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC‐3G3) to patients with advanced soft tissue sarcoma

by Victor M. Villalobos, Gary Mo, Mark Agulnik, Seth M. Pollack, Daniel A. Rushing, Arun Singh, Brian A. Van Tine, Rhian McNaughton, Rodney L. Decker, Wei Zhang, Ashwin Shahir, Damien M. Cronier
Published 2020-02-01

Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United States

by Seth M. Pollack, Neeta Somaiah, Dejka M. Araujo, Mihaela Druta, Brian A. Van Tine, Melissa A. Burgess, Sant P. Chawla, Mahesh Seetharam, Scott H. Okuno, Chet Bohac, Michael Chen, Sergey Yurasov, Steven Attia
Published 2020-07-01

Immunologic Gene Signature Analysis Correlates Myeloid Cells and M2 Macrophages with Time to Trabectedin Failure in Sarcoma Patients

by Brett A. Schroeder, Yuzheng Zhang, Kimberly S. Smythe, Parth Desai, Anish Thomas, Pedro Viveiros, Borislav A. Alexiev, Farres Obeidin, Eleanor Y. Chen, Lee D. Cranmer, Michael J. Wagner, Robin L. Jones, Jean S. Campbell, Robert H. Pierce, Qianchuan He, Seth M. Pollack
Published 2022-03-01

Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond

by Surya Pandey, Meghan E. Cholak, Rishita Yadali, Jeffrey A. Sosman, Marie-Pier Tetreault, Deyu Fang, Seth M. Pollack, Sacha Gnjatic, Rebecca C. Obeng, H. Kim Lyerly, Adam M. Sonabend, José A. Guevara-Patiño, Lisa H. Butterfield, Bin Zhang, Holden T. Maecker, I. Caroline Le Poole
Published 2024-01-01

Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients—A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN)

by Bernd Kasper, Annie Achee, Kathrin Schuster, Roger Wilson, Gerard van Oortmerssen, Rebecca A. Gladdy, Matthew L. Hemming, Paul Huang, Matthew Ingham, Robin L. Jones, Seth M. Pollack, Denise Reinke, Roberta Sanfilippo, Scott M. Schuetze, Neeta Somaiah, Brian A. Van Tine, Breelyn Wilky, Scott Okuno, Jonathan Trent
Published 2021-02-01

MRI Radiomic Features Are Independently Associated With Overall Survival in Soft Tissue Sarcoma

by Matthew B. Spraker, MD, PhD, Landon S. Wootton, PhD, Daniel S. Hippe, MS, Kevin C. Ball, MD, Jan C. Peeken, MD, Meghan W. Macomber, MD, Tobias R. Chapman, MD, Michael N. Hoff, PhD, Edward Y. Kim, MD, Seth M. Pollack, MD, Stephanie E. Combs, MD, Matthew J. Nyflot, PhD
Published 2019-04-01